USPTO serial 99933773
IRULYA THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MILLER, JUSTIN T
- Law office
- TMO LAW OFFICE 137
What this means
Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.
Need help with IRULYA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amanda H. Wilcox
Amanda H. Wilcox Taft Stettinius & Hollister LLP200 Public Square, Suite 3500Cleveland, OH 44114United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of pulmonary, oncology, and neurology diseases and disorders; drug delivery agents in the form of tablets, capsules, oral dissolving tablets, oral disintegrating tablets, injectables, inhalation or nasal formulations, and associated drug-device combinations thereof that facilitate the delivery of pharmaceutical preparations; Inhalers filled with pharmaceutical preparations for the treatment of pulmonary diseases; syringes sold filled with pulmonary, oncology, and neurology pharmaceuticals | ACTIVE | — |
| 010 | Drug delivery devices sold empty, namely, dry powder inhalers, metered dose inhalers, Nebulizers, and Soft mist devices, and parts and components therefor; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Instruments and apparatus provided empty used for the inhalation of pharmaceuticals; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of pulmonary diseases; Nebulizers for medical purposes; Disposable syringes; medical syringes; Syringes for medical purposes and for injections; Syringes for injections; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for the treatment of respiratory conditions | ACTIVE | — |
| 042 | Medical research; pharmaceutical research and development; scientific research and development; medical and scientific research in the field of pulmonary, oncology, and neurology diseases and disorders; testing of pharmaceuticals; pharmaceutical products development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; medical and scientific research in the field of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Product design and development in the field of dry powder inhaler devices and drug delivery systems; providing medical research information in the field of pharmaceuticals | ACTIVE | — |
| 044 | Providing medical information; medical services; providing medical information in the field of pulmonary, oncology, and neurology diseases and disorders; providing medical information, consultancy and advisory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2026 | NWAP | NEW APPLICATION ENTERED | — |